Reported Earlier: Baird Medical Investment Completes Cross-Platform AI Surgical Software, Begins U.S., EU, And China Registration

Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of development for its cross-platform surgical software, officially commencing the registration process in the United States, the European Union, and China.

 

Leveraging a proprietary artificial intelligence model, the system automates core clinical workflows, including anatomical mapping, dynamic treatment planning, and procedural simulations. By integrating diverse diagnostic imaging, the software assists physicians in defining precise surgical pathways and parameters, designed to optimize patient outcomes across a broad spectrum of minimally invasive modalities.

This digital infrastructure is engineered to integrate directly with Baird Medical's upcoming non-invasive and minimally invasive fully automated surgical robotic system. This integration establishes a comprehensive, closed-loop surgical ecosystem, which spans pre-operative analysis and decision-making, intra-operative execution, and post-operative evaluation. This evolution accelerates the Company's commercial roadmap and addresses the increasing global demand for highly integrated, intelligent interventional ecosystems.